Skip to main content
SpringerLink
Log in

Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles (United States)

  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Objective: To compare two methods for calculating lifetime ovulatory cycles (LOC) to determine if more detailed menstrual cycle information results in stronger associations with ovarian cancer. Methods: Using data from 232 cases and 242 controls in a population-based study of ovarian cancer, we compared a standard method for calculating LOC with a second method that had more detailed information on menstrual characteristics. Odds ratios for ovarian cancer by number of LOC were estimated using unconditional logistic regression. Results: The average number of LOC was 29 fewer for the second method that had more detailed menstrual cycle information, as compared to the standard method (p < 0.0001). The difference was due primarily to the second method considering episodes of missed/irregular periods. Associations between LOC and ovarian cancer were weaker for the second method than the standard method. Further analyses suggested that a reduced number of ovulatory cycles due to menstrual irregularity was associated with increased ovarian cancer risk, in contrast to the protective effects observed for fewer ovulatory cycles due to pregnancy or oral contraceptive use. Conclusion: Obtaining additional details on menstrual factors that affect LOC, particularly missed or irregular cycles, provides important information on ovarian cancer risk. Our data suggest that episodes of anovulation due to menstrual disturbances should be evaluated separately from anovulation due to pregnancy or oral contraceptive use.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Fathalla MF (1971) Incessant ovulation-a factor in ovarian neoplasia? Lancet 2: 163.

    Google Scholar 

  2. Cramer DW, Welch WR (1983) Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst 71: 717–721.

    Google Scholar 

  3. Risch HA (1998) Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 90: 1774–1786.

    Google Scholar 

  4. Whittemore AS, Harris R, Itnyre J, and the Collaborative Ovarian Cancer Group (1992) Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Am J Epidemiol 136: 1212–1220.

    Google Scholar 

  5. Schildkraut JM, Bastos E, Berchuck A (1997) Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer. J Natl Cancer Inst 89: 932–938.

    Google Scholar 

  6. Webb PM, Green A, Cummings MC, Purdie DM, Walsh MD, Chenevix-Trench G (1998) Relationship between number of ovulatory cycles and accumulation of mutant p53 in epithelial ovarian cancer. J Natl Cancer Inst 90: 1729–1734.

    Google Scholar 

  7. Weiss NS, Cook LS, Farrow DC, Rosenblatt KA. Ovarian cancer. In: Schottenfeld D, Fraumeni JF Jr., eds. Cancer Epidemiology and Prevention. New York: Oxford University Press, pp. 1040–1057.

  8. Whittemore AS, Harris R, Itnyre J, and the Collaborative Ovarian Cancer Group (1992) Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Am J Epidemiol 136: 1184–1203.

    Google Scholar 

  9. Siskind V, Green A, Bain C, Purdie D (2000) Beyond ovulation: oral contraceptives and epithelial ovarian cancer. Epidemiology 11: 106–110.

    Google Scholar 

  10. De Leo V, Lanzetta D, Morgante G, De Palma P, D'Antona. (1997) Inhibition of ovulation with transdermal estradiol and oral progestogens in perimenopausal women. Contraception 55: 239–243.

    Google Scholar 

  11. Schildkraut JM, Schwingl PJ, Bastos E, Evanoff A, Hughes C (1996) Epithelial ovarian cancer risk among women with polycystic ovary syndrome. Obstet Gynecol 88: 554–559.

    Google Scholar 

  12. Ries LAG, Kosary CL, Hankey BF, Miller BA, Clegg LX, Edwards BK (eds) (1999) SEER Cancer Statistics Review, 1973–1996. NIH Publ. No. 99–2789. Bethesda, MD: National Cancer Institute.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cancer Prevention, Detection, and Control Research Program, Department of Community and Family Medicine, Duke University Medical Center, Durham, NC, 27710, USA

    Patricia G. Moorman, Joellen M. Schildkraut, Brian Calingaert & Marilyn F. Vine

  2. Cancer Prevention, Detection, and Control Research Program, Duke University Medical Center, 239 Hanes House, Trent Drive, Box 2949, Durham, NC, 27710, USA

    Patricia G. Moorman

  3. Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, 27710, USA

    Susan Halabi

  4. Division of Oncology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC, 27710, USA

    Andrew Berchuck

Authors
  1. Patricia G. Moorman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joellen M. Schildkraut
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Brian Calingaert
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Susan Halabi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Marilyn F. Vine
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Andrew Berchuck
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moorman, P.G., Schildkraut, J.M., Calingaert, B. et al. Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles (United States). Cancer Causes Control 13, 807–811 (2002). https://doi.org/10.1023/A:1020678100977

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1020678100977

Search

Navigation